<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00790465</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-08-GR-370-CTIL</org_study_id>
    <secondary_id>achalasia1</secondary_id>
    <nct_id>NCT00790465</nct_id>
  </id_info>
  <brief_title>Efficacy of Dark Chocolate in Achalasia Patients</brief_title>
  <official_title>Efficacy of Dark Chocolate in Achalasia Patients: Placebo-Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Flavanols, present in dark chocolate, were shown to induce Nitric Oxide synthesis. Since
      Nitric Oxide facilitates smooth muscle relaxation, it might ease the relaxation of the LES
      (lower esophageal sphincter)as well.

      The objective of the present study is to evaluate tha efficacy of dark chocolate in improving
      LES relaxation in achalasia patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2008</start_date>
  <completion_date type="Anticipated">November 2010</completion_date>
  <primary_completion_date type="Anticipated">November 2009</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lower Esophageal Sphincter relaxation before and after dark chocolate consumption.</measure>
    <time_frame>day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>achalasia symptoms before and during dark-chocolate consumption</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Achalasia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dark chocolate consumption during manometry and 2 weeks treatment with dark chocolate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>placebo comparator: 7 grams of placebo-chocolate at day 1 during manometry, and than crossover to treatment with dark chocolate for 2 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>dark chocolate</intervention_name>
    <description>21 g/d of dark chocolate for 2 weeks (7 g. before each meal). 7 grams of dark chocolate at day 1 during manometry.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>FruiBel chocolate, Belgium.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo chocolate with crossover to dark chocolate</intervention_name>
    <description>Placebo at day 1 during manometry, and than crossover to dark chocolate for 2 weeks treatment.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>FruiBel chocolate, Belgium</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of &quot;achalasia&quot;

          -  &quot;Achalasia&quot; diagnosis during manometry at day 1 of the study.

        Exclusion Criteria:

          -  pregnancy

          -  pseudoachalasia

          -  consumption of GI-motility modifiers durin 72 hours preceding the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 12, 2008</study_first_submitted>
  <study_first_submitted_qc>November 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2008</study_first_posted>
  <last_update_submitted>November 12, 2008</last_update_submitted>
  <last_update_submitted_qc>November 12, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr. Guy Rosner, gastroenterologist</name_title>
    <organization>Tel-Aviv Sourasky Medical Center</organization>
  </responsible_party>
  <keyword>achalasia</keyword>
  <keyword>lower esophageal sphincter</keyword>
  <keyword>nitric oxide</keyword>
  <keyword>dark chocolate</keyword>
  <keyword>flavanols</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Achalasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

